Braidwell’s Nuvectis Pharma NVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.2M Buy
+1,573,823
New +$33.2M 1.38% 26

Other funds holding NVCT

Braidwell's NVCT Position: Q3 2026 in Review

Braidwell opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 1,573,823 shares worth $33.2M. The stake represents 1.38% of the portfolio and ranks #26 among its holdings.

94 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

  • Braidwell held 1,573,823 shares of Nuvectis Pharma worth $33.2M as of Q3 2026.
  • Nuvectis Pharma was a new Braidwell position in Q3 2026.
  • Nuvectis Pharma made up 1.38% of Braidwell's portfolio in Q3 2026, its #26 holding.
  • 94 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on Braidwell's 13F filing for Q3 2026, filed 16 Nov 2026.